Zurück zu Ihrem Suchergebnis

Beschreibung

Category: Aromatics, Chiral Reagents, Heterocycles, Pharmaceuticals, Intermediates and Fine Chemicals /// Appearance: White Solid /// Application Notes: SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients. /// References: Boyle, J., et al.: Curr. Vasc. Pharmacol., 3, 63 (2005), Jennings, L., et al.: Expert. Opin. Drug Metab. Toxicol., 1, 727 (2005), Chackalamannil, S., et al.: J. Med. Chem., 49, 5389 (2006)